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A new surgical method of treating patients with unstable insulin-dependent diabetes (IDD) has been
developed-that of surgically shunting pancreatic blood into the systemic blood flow with the purpose of
creating a more optimal interaction of subcutaneously administered insulin and pancreas-secreted
glucagon.
The long term results of the operation depend on the patency of a splenorenal anastomosis. This has
been studied by following up 137 patients over periods from half a year to three years. Anastomotic
patency was determined by renal and splenic venography and celiacy arteriography, which revealed a
patent anastomosis in 114 patients, and an obliterated one in 23.
Patients with patent anastomoses showed a lowering of glycosylated hemoglobin (HbAlc) from
13.3+0.03% to 9.3+0.6%, p < 0.05, a decrease of the injected insulin dose from 0.97+0.04 to 0.72+0.03 U/
kg, p < 0.05, disappearance or considerable abatement of pain in the lower extremities, and of hypogly-
cemia. Improvement of clinical status was accompanied by an increase of glucagon in the systemic blood
stream from 60.8+10.1 to 91.5+9.4 pg/ml, p < 0.05, a rise of tissue oxygen pressure, PO2, from 49.2+2.4
to 58.1+1.9 mm Hg, p < 0.05. In patients with oblivious anastomoses postoperative HbAlc levels did not
change from preoperative values: 12.9+0.4% and 12.8+0.7%, p < 0.05, respectively; the insulin dose
remained the same-0.91 +0.07 U/kg and 0.85+0.07 U/kg, p < 0.05, no rise of the systemic blood glucagon
content was noted, and former complaints continued.
The suggested method is not an alternative for insulin therapy, but considerably enhances its potential.
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INTRODUCTION
It is common knowledge that the basis of the patho-
genesis of insulin-dependent diabetes (IDD) is insuffi-
ciency of insulin. The role of insulin antagonists,
glucagon among them, in disturbances of glucose me-
tabolism still remains unclear. Some reports indicate
that glucagon enhances glucose production by the liver,
and that its secretion in the pancreas of IDD patients
increases 1-4. Moreover, it has been demonstrated that
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also enhanced in IDD patients is the function of the
contrinsular hormones of the adrenal glands 1.
Glucose homeostasis is maintained by the production
of glucose in the liver and its utilization by peripheral
tissues; it is controlled by the interaction of insulin and
anti-insulin hormones. Exogenous insulin is injected
into IDD patients subcutaneously, with only part of it
reaching the liver where-as all the endogenously secreted
glucagon enters the liver via the splenic and portal veins.
The lack of correlation of the injected insulin with
endogenous glucagon in the tissues may be one of the
causes of the insufficient effect of insulin therapy.
Experimental research we carried out earlier in two
diabetes mellitus models in dogs (subtotal resection of
the pancreas and alloxan administration) demon-
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strated that deflection of venous blood from the pan-
creas into the systemic blood flow, bypassing the liver,
results in the lowering ofglycemia and reduction ofthe
level of triglycerides5-7.
Since 1986 we have performed the operation of
placing a distal venous splenorenal anastomosis in
409 IDD patients. The indication for surgery was
a form of the disease resistant to insulin treatment,
with an unstable course and rapid progression of
microangiopathy. The operation allows shunting
of the venous blood flowing from the pancreas into
the systemic blood flow, which should reduce the
effect ofglucagon on the liver, improve the correlation
between injected insulin and endogenous glucagon
both in the liver and in peripheral tissues. Long term
results of surgery over periods from 2 to 5 years
were followed up in 207 persons. Stabilization
of the course of diabetes and the development
of angiopathy, accompanied by the disappearance
or abatement of complaints of fatigue and pain
in the lower extremities, occurred in 75 percent of
cases.
The purpose of this investigation was to determine
how remote results of surgery depend on the patency
of the splenorenal anastomosis.
MATERIALS AND METHODS
Angiographic examinations of 137 randomized IDD
patients were carried out a considerable time after
surgery. In order to demonstrate that the results de-
pended on anastomotic patency rather than anything
else, apart from the randomized group, patients were
taken at various postoperative periods: 74 at 6
months, 54 at a year, 8 at two years, and 4 at three
years after the operation. This corresponded to the
sequence of their readmission for follow-up examina-
tions. Patients who declined to undergo angiography
were excluded from the study.
The age of the patients varied from 16 to 52
years (median age- 29.5+0.4 years), duration of dis-
ease from 1.5 to 27 years (median- 10.5+0.3 yrs).
A labile course of DM was observed preoperatively
in 72 of the patients, 31 of them had a history of
hypoglycemic coma, 23 of hyperglycemic coma,
18 a combination of hypo- and hyperglycemic co-
mas. The median dose of exogenous insulin was
0.9+0.02 U/kg, median daily glycemia- 12.2+0.3
mM/liter, the level of glycosylated hemoglobin-
13.3+0.3%.
Surgical Techniques
Laparotomy was performed. The splenic and renal
veins were approached through the lesser sac. The
parietal peritoniumwas dissected along the lower edge
of the pancreas to mobilize the splenic vein at a dis-
tance of 3-5 cm from the root of the portal vein. The
small pancreatic branchlets were carefully ligated and
dissected. Another incision of the parietal peritonium
was made in the projection ofthe left renal vein, which
was mobilized at a distance of 4-5 cm. After placing
clamps the splenic vein was ligated and dissected at the
point where it formed the portal vein, an aperture was
formed in the renal vein and an end-to-side spleno-
renal anastomosis was created with a continuous vas-
cular suture, using 5/0-7/0 Prolene and catgut.
Angiographic Techniques
Angiographic examinations were made with a GEM
unit fromThomson Benelux Co., and using a Mark IV
system from Medrad Co. for the automatic adminis-
tration of the Verographin 60% contrast medium. Ex-
amination was started with renal venography by the
catheterization of the left renal vein using the
Seldinger technique, using a ’pig-tail’ catheter. When
possible, selective splenic venography was performed
if the splenic vein was amenable to catheterization via
the region of the splenorenal anastomosis. A catheter
of original design was used for this purpose. In cases
when the above techniques failed to reveal the splenic
vein, arteriography was carried out, for which a hook-
type catheter was used. In addition to the arterial
phase, the distribution ofthe contrastmedium into the
reverse venous phase was studied. In 14 patients pre-
senting with patent anastomoses, both renal veno-
graphy and arteriography were performed in order to
verify the anurons of radiograph interpretations in
patients with patent and obstructed anastomoses. All
the examinations were additionally videorecorded.
Biochemical and Hormonal Investigations
Blood glucose levels were determined by the ortho-
toluidine technique. Blood was collected by fingertip
puncture five times within 24 hours. Glycolysated
hemoglobin (HbAlo) was determined by the method of
affinity chromatography with the use of borphenyl
agarose as sorbent.
The hormonal profile was assessed by the level of c-
peptide, glucagon and cortisol. Radioimmune assay
kits from Byk-Sangtech (FRG), Serono (Switzerland),
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Kidney function was assessed by the rate of glome-
rular filtration, determined by 24-hour endogenous
creatinine clearance.
Evaluation of Tissue Oxygenation
Tissue oxygen balance was determined by the gas
content ofthe blood with the aid ofan apparatus from
Corning Co. (U.K.). Bood samples for pO and pCO2
were drawn from the artery and vein of the forearm.
Percutaneous measurements were taken with the aid of
a TM-220 oxymonitor from Radiometer Co. (Den-
mark), fitted with heating electrodes (43C). The elec-
trodes were secured on the lower third of the shin.
Evaluation of the Vegetative Nervous System
The state ofdiabetic autonomic neuropathywas deter-
mined from the degree of respiratory arrhythmia dur-
ing quiet (G1) and forced (G) respiration, by the 30/15
index 9. The degree of respiratory arrhythmia was as-
sessed by the mean square variational deviation in the
duration of cardiac intervals during quiet and forced
respiration (3 deep 5-second-long inhalations and
exhalations) in milliseconds. The 30/15 index was de-
termined by correlation of the length of the thirtieth
cardiac interval to that ofthe fifteenth cardiac interval
after the patient changed from the horizontal to the
vertical position. The pulse rate was determined from
the mean cardiac interval length at quiet breathing.
Statistical Processing
The data obtained were processed on an IBM PC/AT
computer, using a Statographics statistical package,
USA.
anastomosis (Figure 1). In 14 patients renal veno-
graphy was combined with arteriography, both tech-
niques revealing the filling of the splenic vein. There
was no filling ofthe splenic vein in 53 patients, so all of
them underwent arteriography. In the reverse venous
phase 30 patients showed an image of the splenic vein
to the level of the catheter placed in the left renal vein
(Figure 2), indicating patency of the anastomosis. In
the other 23 patients contrast filling ofthe splenic vein
either never occurred, or was detected as a short
length from the pancreas with a gap between this
portion and the catheter placed in the left renal vein
(Figure 3). The anastomosis in these 23 patients was
held to be obstructed. In 19 patients arteriography
was performed as the only method; constrast filling of
the splenic vein was observed. Selective splenic
venography was performed in 39 patients, showing
anastomotic patency (Figure 4). Thus, angiography
found a patent anastomosis in 114 persons (Group 1)
and an obliterated anastomosis in 23 persons (Group
2). Before surgery the patients in the two groups did
not differ in duration of the disease (10.3+0.73 and
9,6+2.1 years respectively, p > 0.05), age (29.5+1.04
and 26.8+2.1 years), exogenous insulin dose (0.92+0.03
and 0.87+0.05 U/kg, p > 0.05) or mean daily glycemia
level (11.9+2.7 and 13.2+1.1 mM/liter, p > 0.05).
3. Exogenous Insulin Dose
In patients with patent anastomoses the insulin dose
was postoperatively reduced from 0.97+0.04 to
0.72+0.03 U/kg, p < 0.05. In patients with blocked
anastomoses the dose did not significantly change:
0.91+0.07 U/kg and 0.85+0.07 U/kg. p > 0.05. The
insulin preparation and pattern of administration did
not change in these patients.
RESULTS
1. Immediate Results ofSurgery
All the 137 patients withstood the operation well, and
were duly discharged from the clinic. Complications
occurred in 11 cases" 4 had an exacerbation ofchronic
pyelonephritis, 5-focal pneumonia, and 2-fistulae in
the region of the surgical suture line.
4. Changes in Glycolysated Hemoglobin
Before surgery the patients in Groups and 2 hardly
differed in HbAlo levels: 13.3+0.3 and 12.9+0.4% re-
spectively, p > 0.05. After the operation patients with
a patent anastomosis showed a drop in the HbAlc level
to 9.3+0.6%, p < 0.05; patients with obstructed anas-
tomosis showed no change: 12.8+0.7%. p > 0.05.
2. Results ofAngiography
Renal venography was performed in 79 patients, in
26 of whom there was contrast visualization of
the splenic vein, indicating patency of the splenorenal
5. Hormonal Study Findings
These studies were carried out in 31 patients with
patent anastomoses and 11 with impassable ones. Be-
fore surgery the c-peptide levels in these patients prac-194 E.I. GALPERIN et al.
Figure 3 Arteriogram. Reverse venous phase with impassable
anastomosis (see text).
Figure Renal venogram of patent splenorenal anastomosis.
Figure 2 Arteriogram. Reverse venous phase with patent
splenorenal anastomosis.
Figure 4 Selective splenic venogram.PANCREATIC BLOOD SHUNT IN DIABETICS 195
tically did not differ, being 0.45+0.17 and 0.33+0.16
ng/ml respectively, p > 0.05. After surgery the c-
peptide values in patients with patent anastomoses
increased to 0.84+0.18 ng/ml, p < 0.05, while in those
with impassable anastomoses they did not change:
0.26_+0.08 ng/ml, p > 0.05.
Nor did the two groups differ in preoperative
glucagon content. 60.8_+10.1 pg/ml and 77.8_+10.0 pg/
ml, p > 0.05. After surgery the glucagon content in
patients with patent anastomoses increased to
91.5_+9.4 pg/ml, p < 0.05, in those with impassable
anastomoses there was no change: 69.6_+9.0 pg/ml,
p > 0.05.
The dynamics of anti-insulin hormones (glucagon
and cortisol) was examined pre- and postoperatively in
9 patients (Table 1). The splenorenal anastomosis was
passable in all of them. After surgery the glucagon
level in the systemic blood flow increased in all the
patients, and this was accompanied by a drop of the
cortisol content in 8 persons.
6. Filtering Capacity of the Kidneys
The glomerular filtration rate (GFR) was examined in
96 patients. They were divided into 3 groups according
to preoperative GFR findings: 41 patients had a
diminished GFR at 64.9_+1.6 ml/min, 34 patients had
normal GFR at 97.7_+2.1 ml/min, and in 21 it was in-
creased to 164.0_+6.1 ml/min. In patients with a
patent anastomosis low filtration rates rose to 90.0_+7.3
ml/min, p < 0.05 (29 persons), normal filtration did not
change-102.6_+5.8 ml/min (30 persons), elevated GFR
tended to normalization-143.3_+13.8 ml/min, p > 0.05
(21 persons). In patients with an impassable anastomosis
and low GFR, it did not rise- 72.7_+7.8 ml/min, p > 0.05
(12 persons), those with normalfiltrations showed adrop
to 73.3_+3.6 ml/min, p < 0.05 (4 persons).
7. Tissue Oxygen Balance
The state of tissue oxygenation was studied
in 25 patients. Preoperative epicutaneous measurement
found pO equal to 49.2_+2.4mm Hg, pCO 44.4_+0.98
mm Hg. After surgery the pO of21 patients with patent
anastomoses increased to 58.1_+ 1.93 mm Hg, p < 0.05.
ThepCO did not change-41.7_+1.2 mm Hg. In patients
with impassable anastomoses the epicutaneously meas-
uredpO was low-39.6_+2.7mm Hg, p < 0.05; thepCO
did not differfrom the preoperative level. In patients with
a patent anastomosis (n 21) the arterial blood pO was
93.6_+5.8 mm Hg, in venous blood it was 22.8_+2.7 mm
Hg; arterial bloodpCO was 26.7_+ 1.9mm Hg, in venous
blood it was 41.3_+3.3 mm Hg. In patients with an ob-
structed anastomosis (n 4) arterial blood pO was
97.5_+2.1 mm Hg, in venous blood it was 30.2_+ 1.5 mm
Hg; arterial bloodpCO was 36.5_+0.7mm Hg, in venous
blood it was 41.8+3.2mm Hg.
8. Vegetative Innervation of the Heart
This was studied in 26 patients before and after sur-
gery. The splenorenal anastomosis was patent in 22.
The G index increased from 25.4_+2.9 msec by
10.5_+3.4 msec, p<0.01; G2-from 62.8_+8.0 msec
by 21.9_+6.9 msec, p < 0.01; the 30/15 index from
1.065_+0.02 by 0.092_+0.035, p<0.05. Here the
pulse rate decreased from 79.9_+3.0 by 5.8_+2.2
pulsations per minute, p < 0.05. In 4 patients with
an obstructed anastomosis no statistically significant
index changes occurred.
9. Patients Complaints
Before surgery 121 patients complained of pain in the
lower extremities. Such pain disappeared postopera-
Table 1 Anti-Insulin Hormone Level in Blood on Empty Stomach Before (PRE) and After (POST)Surgery.
Patient Sex Age Duration Insulin dose Glugagon level Cortisol level
No. ofdisease (U/kg) (pg/ml) (nm/l)
years pre post pre post pre post
M 19 14 1.5
2 M 38 2 0.6
3 F 30 20 0.8
4 M 33 7 0.5
5 M 22 12 0.75
6 M 32 5 0.61
7 F 24 19 1.0
8 F 27 19 0.98
9 M 34 8 1.2
1.1 72.2 94.4 1911.4 1559.9
0.6 77.2 153.8 759.0 694.4
0.8 21.0 76.2 827.7 388.4
0.14 76.1 100.5 1060.8 967.6
0.43 60.2 86.5 1559.4 992.6
0.64 16.6 59.2 1436.1 1492.2
0.8 50.8 70.0 1850.9 779.8
0.77 63.3 80.4 2466.0 836.1
1.0 68.9 196.5 1188.9 777.5196 E.I. GALPERIN et al.
tively in 52 patients with patent anastomoses, abated
considerably in 33, and persisted in only 11. At the
same time pain persisted in 12 of the 19 patients with
obstructed anastomoses, abated in 4 and disappeared
in 3 (the difference between the groups by the x crite-
rion is statistically significant, p < 0.001).
Before surgery hypoglycemia occurred in 110 pa-
tients. After surgery 54 patients with patent anas-
tomoses stopped complaining of hypoglycemia, in 27
it occurred seldom, and in only 11 patients the opera-
tion produced no improvement. Out ofthe 18 patients
with impassable anastomoses 10 had postoperatively
the same complaints, in 6 the hypoglycemia states
were more easily tolerated, and in only 2 patients
hypoglycemia disappeared (the difference between the
groups by the x criterion is statistically significant,
p < 0.001).
DISCUSSION
Changes in the blood discharged from hormone-
producing organs (pancreas and adrenal glands)
is used in metabolic surgery to improve the patients’
status in glucagon storage disease, hereditary
hyperlipedemial, some forms of hypertension2,
and chronic hepatitis3. In these cases the liver, as
the chief organ of hormone metabolization, is
eitherincluded in2’13’, or excluded from’ the blood
flow.
The liver is the chief organ for the metabolism
of pancreatic hormones, determining glucose homeo-
stasis. Experiments on diabetes mellitus models
show that in the case of disturbances of insulin
secretion the liver’s glucose production increases and
is not blocked by the administration of glucose4.
One of the causes might be increased glucagon
secretion. Also important is insulin degradation in the
liver15, which lowers the content in the systemic blood.
On the strength of data about insulin degradation
in the liver Le Veen used a splenorenal anastomosis
in dogs with subtotal resection of the pancreas in
order to save exogenous insulin and observed a drop
in the blood glucose level6. We have not found reports
in the literature confirming such investigations in
clinical practice.
In our view, the liver’s regulating role in maintain-
ing glucose homeostasis in IDD is limited by the
fact that subcutaneously injected insulin is distributed
in the main in peripheral tissues, while for endogenous
insulin it is the liver. The entry of insulin into
the liver while there is relative hypoinsulinemia
in the portal vein system and hyperinsulinemia in
peripheral tissues creates conditions for noncompen-
sated neoglucogenesis, upsets the formation of glyco-
gen from glucose, complicates the interaction of the
liver, muscular and fatty tissues in the exchange of
energy substrates (glucose, free fatty acids, lactate and
amino acids). This is possibly one of the causative
factors in the development of hypo- and
hyperglycemic states and determines the difficulty of
attaining a stable clinical effect with subcutaneous
administration of insulin.
Surgical placement of a distal venous splenorenal
anastomosis creates conditions for a more optimal
correlation between the injected exogenous insulin and
endogenous glucagon in the tissues.
The main point up this communication was to reveal
the dependence of surgical results on the patency ofthe
splenorenal anastomosis. Our investigations demon-
strated that in an overwhelming majority of patients
with a patent anastomosis the main complaints disap-
peared or considerably abated, andHbA, an indicator
not only of carbohydrate, but also of fat metabolism
compensaton was, lowered7. In patients with an im-
passable anastomosis, when there is practically no
shunting of glucagon into the systemic blood flow, the
complaints persisted, and the HbA level did not
drop. We excluded the possibility of the surgical re-
sults being influenced by the postoperative pattern of
insulin therapy. The main factor affecting the results
of surgery and the requirement of exogenous insulin,
was the patency or impassability of the splenorenal
anastomosis.
A number of experiments carried out allow us
to presuppose the mechanisms whereby the patients’
postoperative improvement takes place. It is well
known that disturbances of tissue microcirculation
and oxygenation are largely determined by the
conditions of microangiopathic development.
Epicutaneous measurement in patients with
patent anastomoses showed higher oxygen pressures
than in cases of impassable anastomoses, whereas
this index for arterial blood was the same in
both groups. This perhaps points to improvement
of capillary blood flow. At the same time the
venous blood pO and the arterial blood pCOa in
patients with a patent anastomosis was lower than
when the anastomosis was obliterated. This gives
grounds for noting better oxygen utilization by the
tissues after the operation. Improvement of
microcirculation may be a factor in the normalization
of the GFR and an improvement in the vegetative
innervation of the heart.PANCREATIC BLOOD SHUNT IN DIABETICS 197
The examination of glucagon levels yielded impor-
tant information. Preoperatively the patients’
glucagon level in a peripheral vein were practically
identical. After surgery a rise of glucagon levels was
observed only in patients with patent anastomoses.
Thus, an improvement of the clinical status occurred
upon an increase of glucagon in the systemic blood
stream, which, possibly, created conditions for its
more optimal interaction with subcutaneously in-
jected insulin.
There are some things which we are still unable to
explain, but which we believe warrant attention. Ob-
served in patients with patent anastomoses was a rise
of the c-peptide level on an empty stomach. Whether
this results from the improved functioning of the pan-
creas or is a response to stimulation by endogenous
glucagon, which postoperatively affects the beta-cells
of the pancreas via the systemic blood flow, is not
clear.
Of certain interest is glucagon’s interaction with
adrenal hormones, which also possess a contrainsular
action and play an important role in the regulation of
vascular tone and microcirculation. Increased secre-
tion by the adrenal glands of contrainsular hormones
in diabetics is regarded as a response to metabolic
stress, which during the long term course of diabetes
gets transformed into an injury mechanism, promot-
ing the development of microangiopathyTM. Glucagon
and the contrainsular hormones of the adrenals are to
a large extent synergists, providing the body with
metabolic substrates1. At the same time, in distinction
to the adrenal hormones, glucagon does not produce a
vasospastic effect. As our studies have shown (see
Table 1), extrahepatic shunting of glucagon into the
systemic bloodflow is accompanied by a diminution of
the cortisol level. Further investigations will clarify
whether these changes are regular, and establish their
role in altering the microcirculation.
An analysis of the findings presented in this paper
convincingly points to the dependence of surgical re-
sults on the patency of the created splenorenal
anastomosis. The chief result of the operation is
stabilisation of the diabetic course.
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